No clinical trial site will participate in a trial without being paid. The clinician in charge of the trial is paid indirectly by the clinical trial sponsors through their system. These clinicals all want to curry favor with sponsors to attract more trial business. Clinical trial operations are normally an attractive profit center for a medical system.
Read the peer-reviewed criticisms. There is significant bias in the NWBO Phase 3 trial analysis and reporting. Read the peer-reviewed journal article, it is clear. Of particular note is Dr. Bosch having so much control in the statistical analysis and reporting and the external comparator identification.
But the regulators will see that clearly in the regulatory application filing.
Market Data 
Markets 
AI
